Frequent methylation of the KLOTHO gene and overexpression of the FGFR4 receptor in invasive ductal carcinoma of the breast.

Abstract

Invasive ductal carcinoma of the breast is the most common cancer affecting women worldwide. The marked heterogeneity of breast cancer is matched only with the heterogeneity in its associated or causative factors. Breast cancer in Saudi Arabia is apparently an early onset with many of the affected females diagnosed before they reach the age of 50 years. One possible rationale underlying this observation is that consanguinity, which is widely spread in the Saudi community, is causing the accumulation of yet undetermined cancer susceptibility mutations. Another factor could be the accumulation of epigenetic aberrations caused by the shift toward a Western-like lifestyle in the past two decades. In order to shed some light into the molecular mechanisms underlying breast cancer in the Saudi community, we identified KLOTHO (KL) as a tumor-specific methylated gene using genome-wide methylation analysis of primary breast tumors utilizing the MBD-seq approach. KL methylation was frequent as it was detected in 55.3 % of breast cancer cases from Saudi Arabia (n = 179) using MethyLight assay. Furthermore, KL is downregulated in breast tumors with its expression induced following treatment with 5-azacytidine. The involvement of KL in breast cancer led us to investigate its relationship in the context of breast cancer, with one of the protagonists of its function, fibroblast growth factor receptor 4 (FGFR4). Overexpression of FGFR4 in breast cancer is frequent in our cohort and this overexpression is associated with poor overall survival. Interestingly, FGFR4 expression is higher in the absence of KL methylation and lower when KL is methylated and presumably silenced, which is suggestive of an intricate relationship between the two factors. In conclusion, our findings further implicate "metabolic" genes or pathways in breast cancer that are disrupted by epigenetic mechanisms and could provide new avenues for understanding this disease in a new context.

• Authors: Ashraf Dallol, Abdelbaset Buhmeida, Adnan Merdad, Jaudah Al-Maghrabi, Mamdooh A Gari, Muhammad M Abu-Elmagd, Aisha Elaimi, Mourad Assidi, Adeel G Chaudhary, Adel M Abuzenadah, Taoufik Nedjadi, Eramah Ermiah, Shadi S Alkhayyat, Mohammed H Al-Qahtani
• Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine (Tumour Biol) Vol. 36 Issue 12 Pg. 9677-83 (Dec 2015) ISSN: 1423-0380 [Electronic] Netherlands
• PMID: 26152288 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• FGF19 protein, human
• Fibroblast Growth Factors
• FGFR4 protein, human
• Receptor, Fibroblast Growth Factor, Type 4
• Glucuronidase
• Klotho Proteins

Topics

• Adult
• Aged
• Aged, 80 and over
• Carcinoma, Ductal, Breast (genetics, pathology)
• Cell Line, Tumor
• CpG Islands
• DNA Methylation (genetics)
• Epigenesis, Genetic
• Female
• Fibroblast Growth Factors (biosynthesis, genetics)
• Gene Expression Regulation, Neoplastic
• Glucuronidase (genetics)
• Humans
• Klotho Proteins
• Middle Aged
• Promoter Regions, Genetic
• Receptor, Fibroblast Growth Factor, Type 4 (biosynthesis, genetics)